FindTrial
Sign In

The detection of RAS components in the plasma of VTE patients

The diagnostic value of hsa-miR-520g in the plasma of acute pulmonary embolism patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-DOD-14005735
Enrollment
Unknown
Registered
2014-12-23
Start date
2013-10-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

VTE

Interventions

Gold Standard:
Index test:

Sponsors

Sir Run Run Shaw Hospital, Medical School of Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. To be aged 18 to 75 years; 2. the firstly diagnosed acute pulmonary embolism, anticoagulation and thrombolysis were not used.

Exclusion criteria

Exclusion criteria: 1. women in pregnancy; 2. severe illness in other system; 3. surgery and trauma in recent 3 months.

Design outcomes

Primary

MeasureTime frame
Serum miRNA molecular hsa-miR-520g concentration;—

Countries

China

Contacts

Public ContactRuifeng Zhang
zrf1977313@yeah.net+86 13968048103

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026